The US Food and Drug Administration (FDA) is set to form new alliances to accelerate the development of medical countermeasures for the new coronavirus that emerged in Wuhan, China last month.
The regulator will work with interagency and international partners, product developers and global regulators. The focus is to develop and make available medical products to treat, mitigate, prevent and diagnose such outbreaks.
FDA is sharing process updates to aid developers and issuing important information for the public to help in the development of medical products.
The coronavirus currently lacks diagnostics and the FDA is collaborating with public health partners to advance and share reference materials for diagnostic development.
FDA commissioner Stephen Hahn said: “We are actively leveraging the vast breadth of the FDA’s expertise and have begun employing the full range of our public health authorities to facilitate the development and availability of investigational medical products to help address this urgent public health situation.”
Meanwhile, Anti-Coronavirus Foundation has been established in Geneva, Switzerland to fund research for the development of a coronavirus vaccine.
To ensure transparency, the foundation will manage all transactions in CRON blockchain run by CryptOcean. Anyone can use the blockchain platform to send funds for research at the foundation.
Furthermore, information analytics company Elsevier has created a Novel Coronavirus Information Center, providing access to medical, clinical research and scientific information regarding the virus.